PharmaCielo Ltd. PCLOF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.61M | 1.84M | 1.27M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.61M | 1.84M | 1.27M | -- | -- |
| Cost of Revenue | 1.67M | 1.32M | 1.48M | -- | -- |
| Gross Profit | 937.00K | 518.70K | -211.10K | -- | -- |
| SG&A Expenses | 3.11M | 2.89M | 3.05M | -- | -- |
| Depreciation & Amortization | 118.60K | 58.50K | 100.00K | -- | -- |
| Other Operating Expenses | -10.60K | -97.60K | -796.60K | -- | -- |
| Total Operating Expenses | 4.89M | 4.17M | 3.83M | -- | -- |
| Operating Income | -2.28M | -2.33M | -2.56M | -- | -- |
| Income Before Tax | -2.70M | -2.60M | -3.31M | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.70 | -2.60 | -3.31 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.70M | -2.60M | -3.31M | -- | -- |
| EBIT | -2.28M | -2.33M | -2.56M | -- | -- |
| EBITDA | -1.21M | -1.12M | -1.68M | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.02 | -- | -- |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -- | -- |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -- | -- |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -- | -- |
| Average Basic Shares Outstanding | 772.95M | 753.93M | 748.36M | -- | -- |
| Average Diluted Shares Outstanding | 772.95M | 753.93M | 748.36M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |